Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)

Condition:   Advanced Breast Cancer Interventions:   Drug: Abemaciclib;   Drug: Aromatase Inhibitors Sponsor:   University of Milano Bicocca Not yet recruiting

Source: ClinicalTrials.gov - January 13, 2020 Category: Research Source Type: clinical trials